Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.53% | -6.43% | -4.61% | -5.51% | -9.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.53% | -6.43% | -4.61% | -5.51% | -9.45% |
| Cost of Revenue | -10.91% | -19.43% | -14.99% | -17.68% | -12.96% |
| Gross Profit | 2.34% | 11.11% | 9.07% | 10.71% | -5.33% |
| SG&A Expenses | -7.35% | -19.83% | -26.11% | -30.28% | -15.94% |
| Depreciation & Amortization | -4.04% | 19.42% | 26.89% | 65.89% | 34.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.32% | -18.65% | -18.43% | -20.24% | -13.02% |
| Operating Income | 31.87% | 190.06% | 629.09% | 1,363.89% | 31.66% |
| Income Before Tax | 109.50% | -38.66% | 244.94% | 108.17% | -869.82% |
| Income Tax Expenses | 430.94% | -26.54% | 7.10% | -66.54% | -130.67% |
| Earnings from Continuing Operations | 93.22% | -17.75% | 92.61% | 102.70% | -3,391.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.85% | -145.50% | -278.19% | -111.58% | 67.47% |
| Net Income | 90.88% | -48.72% | 80.07% | 101.63% | -1,080.75% |
| EBIT | 31.87% | 190.06% | 629.09% | 1,363.89% | 31.66% |
| EBITDA | 17.72% | 88.71% | 164.15% | 284.66% | 23.84% |
| EPS Basic | 91.15% | -35.19% | 82.22% | 101.46% | -953.85% |
| Normalized Basic EPS | 23.08% | -1,600.00% | 200.53% | -51.05% | 168.78% |
| EPS Diluted | 91.15% | -35.19% | 82.22% | 101.46% | -953.85% |
| Normalized Diluted EPS | 23.08% | -1,600.00% | 200.53% | -51.05% | 168.78% |
| Average Basic Shares Outstanding | 2.93% | 9.98% | 12.12% | 12.15% | 12.07% |
| Average Diluted Shares Outstanding | 2.93% | 9.98% | 12.12% | 12.15% | 12.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
